TABLE 2.
Antimicrobial susceptibilities of isolates of GNR positive for blaIMP gene
Drug | MIC (μg/ml)a
|
||||||||
---|---|---|---|---|---|---|---|---|---|
P. aeruginosa (n = 53)
|
Other GNF bacteria (n = 13)
|
S. marcescens (n = 13)
|
|||||||
Range | 50% | 90% | Range | 50% | 90% | Range | 50% | 90% | |
Piperacillin | 16–>128 | 64 | >128 | 32–>128 | >128 | >128 | 16–>128 | 16 | >128 |
CAZ | 64–>128 | >128 | >128 | 64–>128 | 128 | >128 | 64–>128 | >128 | >128 |
Aztreonam | 1–>128 | 8 | 128 | 16–>128 | 128 | >128 | 1–>128 | 2 | 16 |
Cefozopran | 128–>128 | >128 | >128 | 128–>128 | >128 | >128 | 128–>128 | >128 | >128 |
IPM | 2–>128 | 8 | >128 | 8–>128 | 128 | >128 | 16–>128 | >128 | >128 |
Meropenem | 4–>128 | 16 | >128 | 8–>128 | >128 | >128 | 128–>128 | >128 | >128 |
Gentamicin | 0.25–>128 | >128 | >128 | 16–>128 | >128 | >128 | 2–>128 | 4 | 32 |
Ciprofloxacin | 0.06–32 | 4 | 32 | 0.125–32 | 16 | 32 | 0.5–>128 | 2 | 4 |
50% and 90%, MICs at which 50 and 90% of isolates are inhibited, respectively.